Document is current
Any future updates will be listed below
-
Authors
Winter, Nils R. https://orcid.org/0000-0002-6241-1492
Gruber, Marius
Hahn, Tim https://orcid.org/0000-0001-6541-3795
Repple, Jonathan https://orcid.org/0000-0003-1379-9491
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (521379614)
- License Information
-
More Information
Article History
First Online: 4 June 2026
Competing interests
: J.R. received speaker’s honoraria from Janssen, Hexal, Neuraxpharm and Novartis. M.G. has received remuneration from Janssen for consultancy services. T.H. has received remuneration from SpringHealth for consultancy services.
